Atlas Trials

Immunotherapy Vaccine and Herceptin in Breast Cancer

Clinical trial NCT03014076 · COMPLETED

Trial details

NCT number
NCT03014076
Sponsor
Cancer Insight, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breastcancer
Start date
2008-01-01
Primary completion
2016-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.